New Research Shows: Neurofeedback Is An 'Evidence-Based' Treatment For ADHD
Neurofeedback is a treatment where real-time feedback is provided for specific brain activity (most often EEG) in order to learn the brain to suppress or produce specific brain activity. This method was initially discovered for the treatment of Epilepsy and from 1976 investigated further for the treatment of ADHD. This technique has become more popular by clinicians worldwide, and is currently provided for the treatment of several disorders. Critics have often questioned the efficacy of Neurofeedback and whether it can be considered an Evidence Based treatment or not.
In collaboration with researchers from Tubingen University (Germany), Radboud University (Nijmegen, the Netherlands), Brainclinics and EEG Resource Institute a so-called meta-analysis was conducted on all published research about Neurofeedback treatment in ADHD. This meta-analysis included 15 studies and 1194 ADHD patients. Based on this study - which will be published in the July issue of EEG and Clinical Neuroscience - it could be concluded that Neurofeedback can indeed be considered an Evidence-Based treatment for ADHD. The results show that neurofeedback treatment has large and clinically significant effects on Impulsivity and Inattention and a modest improvement of Hyperactivity.
These findings apply to Neurofeedback treatment for ADHD, but do not automatically imply that Neurofeedback can be considered evidence based for any disorder. The efficacy of Neurofeedback has to be assessed separately for each disorder. For example, a meta-analysis of EEG biofeedback in Epilepsy is published in the same issue of EEG and Clinical Neuroscience demonstrating clinical efficacy in the treatment of epilepsy.
Interested clients are advised to make an informed choice regarding Neurofeedback therapists, since there is a large heterogeneity in neurofeedback treatment approaches and clinicians. It is advised to look for psychologists or physicians who are a member of a professional organization such as the International Society for Neurofeedback and Research (ISNR: http://www.isnr.org) or other professional organizations.
Literature
Arns, M., de Ridder, S., Strehl, U., Breteler, M. & Coenen, A. Efficacy of Neurofeedback Treatment in ADHD: The effects on Inattention, Impulsivity and Hyperactivity: a Meta-Analysis. EEG and Clinical Neuroscience; 40(3), 180-189.
Brainclinics is specialized in Personalized Medicine, applied Neuroscience and diagnostics of Brain related disorders. Furthermore, Brainclinics is specialized in innovative new - evidence-based - treatments such as rTMS for Depression and Neurofeedback for the treatment of ADHD. Employing applied Brain research Brainclinics strives to improve and personalize treatments in order to achieve more efficacious clinical outcomes (also called Personalized Medicine).
Source: Brainclinics Treatment B.V.
There are no references listed for this article.
Visit our ADHD category page for the latest news on this subject, or sign up to our newsletter to receive the latest updates on ADHD.
Please use one of the following formats to cite this article in your essay, paper or report:
MLA
B.V, Brainclinics Treatment. "New Research Shows: Neurofeedback Is An 'Evidence-Based' Treatment For ADHD." Medical News Today. MediLexicon, Intl., 17 Jul. 2009. Web.
31 Oct. 2016. <http://www.medicalnewstoday.com/releases/157843.php>
APA
B.V, B. (2009, July 17). "New Research Shows: Neurofeedback Is An 'Evidence-Based' Treatment For ADHD." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/157843.php.
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Please note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms of use.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.